Caraceni, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.261
AS - Asia 271
EU - Europa 181
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.260
CN - Cina 127
SG - Singapore 85
IT - Italia 70
SE - Svezia 37
VN - Vietnam 37
FI - Finlandia 19
FR - Francia 16
DE - Germania 13
IN - India 11
HK - Hong Kong 8
DK - Danimarca 7
GB - Regno Unito 7
BE - Belgio 5
EG - Egitto 3
UA - Ucraina 3
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
BR - Brasile 1
CA - Canada 1
EU - Europa 1
LT - Lituania 1
NL - Olanda 1
TR - Turchia 1
Totale 2.718
Salva come PNG Salva come JPEG
Città #
Fairfield 453
Woodbridge 257
Chandler 202
Ashburn 191
Houston 178
Cambridge 164
Seattle 160
Ann Arbor 114
Wilmington 110
Singapore 66
San Diego 48
Boardman 46
Dong Ket 37
Beijing 31
Medford 27
Princeton 27
Santa Clara 26
Padova 24
Des Moines 20
Roxbury 18
Nanjing 14
Helsinki 13
Falls Church 8
Hong Kong 8
Shanghai 8
Changsha 7
Rome 7
Guangzhou 6
Hebei 6
New York 6
Salerno 6
Shenyang 6
Tappahannock 5
Zhengzhou 5
Bologna 4
Hefei 4
Lyngby 4
Tianjin 4
Aarhus 3
Antwerp 3
Jinan 3
Ketsch 3
Kharkiv 3
Los Angeles 3
Milan 3
Nanchang 3
Alexandria 2
Banská Štiavnica 2
Brussels 2
Dearborn 2
Dongguan 2
Kunming 2
London 2
Makati City 2
Ningbo 2
Pavia 2
Saint-Fons 2
Shimla 2
Washington 2
Absecon 1
Amsterdam 1
Augusta 1
Bari 1
Bonndorf 1
Bordeaux 1
Borås 1
Cairo 1
Dallas 1
Esslingen am Neckar 1
Fabriano 1
Florianópolis 1
Frankfurt am Main 1
Geislingen an der Steige 1
Haikou 1
Hounslow 1
Kilburn 1
Macerata 1
Munich 1
North York 1
Piacenza 1
Pune 1
Rockville 1
San Giorgio di Piano 1
Shenzhen 1
Stockholm 1
Taizhou 1
Venezia 1
Verona 1
Wandsworth 1
Yenibosna 1
Totale 2.401
Salva come PNG Salva come JPEG
Nome #
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 161
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 159
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 155
Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis 136
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide 120
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure 119
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology 111
Strategies to Restore Adenosine Triphosphate (ATP) Level After More than 20 Hours of Cold Ischemia Time in Human Marginal Kidney Grafts 109
The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure 106
AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis 106
Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 105
Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe 104
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 102
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 98
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience 96
A Prospective Multicentre Study of the Epidemiology and Outcomes of Bloodstream Infection in Cirrhotic Patients 96
Specific issues concerning the management of patients on the waiting list and after liver transplantation 95
AISF-SIMTI position paper: The appropriate use of albumin in patients with liver cirrhosis 94
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 94
Successful Treatment of CCL4-Induced Acute Liver Failure With Portal Vein Arterialization in the Rat 88
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 87
Protective Effect of Portal Vein Arterialization in Acute Liver Failure Induced by Hepatectomy in Normal and Fatty Liver Rat 85
Portal Vein Arterialization for the Treatment of Post Resection Acute Liver Failure in the Rat 76
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 74
Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding 69
Technical Aspects of Portal Vein Arterialization for Acute Liver Failure: From Rat Lab to Man 67
ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM 44
Totale 2.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.985
article - articoli 9.985
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.970
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020359 0 0 0 0 0 36 67 71 70 54 53 8
2020/2021599 26 73 23 26 18 32 20 71 52 90 77 91
2021/2022457 19 96 39 16 38 25 37 34 18 16 33 86
2022/2023339 73 41 4 51 49 39 1 17 39 1 18 6
2023/2024164 5 26 21 18 4 25 18 7 0 11 17 12
2024/2025203 1 44 29 46 64 19 0 0 0 0 0 0
Totale 2.756